M. R. Vilá

发表

Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein

H. Friess, M. Büchler, H. Hameister, 1997, Oncogene.

Defining new criteria for selection of cell-based intestinal models using publicly available databases

Pascale Anderle, Jon Christensen, Mauro Delorenzi, 2012, BMC Genomics.

Hepatitis A virus receptor blocks cell differentiation and is overexpressed in clear cell renal cell carcinoma.

J. Bellmunt, M. Nadal, A. Meseguer, 2004, Kidney international.

Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity.

A. Meseguer, E. García-Arumí, J. Villarroya, 2011, Biochemical and biophysical research communications.

Altered gene transcription profiles in fibroblasts harboring either TK2 or DGUOK mutations indicate compensatory mechanisms.

A. Meseguer, J. Villarroya, M. Hirano, 2009, Experimental cell research.

Uncoupling protein-1 mRNA expression in lipomas from patients bearing pathogenic mitochondrial DNA mutations.

F. Santorelli, C. Casali, J. Montoya, 2000, Biochemical and biophysical research communications.

HAVCR/KIM-1activates the IL-6/STAT-3Pathway in ccRCC and Determines Tumor Progression and Patient Outcome

E. Itarte, S. Y. Cajal, A. Meseguer, 2014 .

Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency

A. Meseguer, E. García-Arumí, J. Villarroya, 2008, Journal of the Neurological Sciences.

Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer

F. Real, A. Skoudy, M. R. Vilá, 1993, International journal of cancer.

Higher processing rates of Alu-containing sequences in kidney tumors and cell lines with overexpressed Alu-mRNAs.

S. Schwartz, A. Meseguer, M. R. Vilá, 2003, Oncology reports.

Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.

M. Zeviani, S. Eriksson, F. Carrara, 2005, Molecular genetics and metabolism.

An in vitro tool to assess cytochrome P450 drug biotransformation-dependent cytotoxicity in engineered HepG2 cells generated by using adenoviral vectors.

J. Castell, A. Lahoz, M. Fabre, 2013, Toxicology in vitro : an international journal published in association with BIBRA.

Alteration of Nucleotide Metabolism: A New Mechanism for Mitochondrial Disorders

M. Hirano, Y. Nishigaki, M. R. Vilá, 2003, Clinical chemistry and laboratory medicine.

Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA.

I. Nishino, M. Hirano, Y. Nishigaki, 2001, Seminars in cell & developmental biology.

Unchanged thymidine triphosphate pools and thymidine metabolism in two lines of thymidine kinase 2‐mutated fibroblasts

V. Bianchi, C. Rampazzo, M. R. Vilá, 2009, The FEBS journal.

Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance.

W. Dauer, Á. García-Cazorla, H. Akman, 2008, Human molecular genetics.

MtDNA maintenance and stability genes: MNGIE and mtDNA depletion syndromes

M. Hirano, Y. Nishigaki, M. R. Vilá, 2004 .

Reversion of mtDNA depletion in a patient with TK2 deficiency

S. Dimauro, A. Marina, A. Meseguer, 2003, Neurology.

Thymidine Kinase 2 Deficiency-Induced Mitochondrial DNA Depletion Causes Abnormal Development of Adipose Tissues and Adipokine Levels in Mice

Beatriz Dorado, Francesc Villarroya, Michio Hirano, 2011, PloS one.

Role of UEV-1, an Inactive Variant of the E2 UbiquitinConjugating Enzymes, in In Vitro Differentiation and Cell Cycle Behavior of HT-29-M6 Intestinal Mucosecretory Cells

Xavier Estivill, Ferran Sanz, Elena Sancho, 1998, Molecular and Cellular Biology.

Altered expression of master regulatory genes of adipogenesis in lipomas from patients bearing tRNA(Lys) point mutations in mitochondrial DNA.

F. Villarroya, M. Pineda, J. Montoya, 2006, Molecular genetics and metabolism.

HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.

E. Itarte, S. Ramón y. Cajal, A. Meseguer, 2014, Cancer research.

A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2

A. Meseguer, J. Gámez, M. Hirano, 2003, Neurology.

Increased glyceraldehyde‐3‐phosphate dehydrogenase expression in renal cell carcinoma identified by RNA‐based, arbitrarily primed polymerase chain reaction

A. Meseguer, I. de Torres, M. R. Vilá, 2000, Cancer.

Mitochondrial DNA abnormalities and autistic spectrum disorders.

S. Dimauro, C. Sue, D. Shungu, 2004, The Journal of pediatrics.

Transcriptomic and proteomic analysis of liver and muscle alterations caused by surgical stress in rats.

E. García-Arumí, M. Carrascal, J. Abian, 2005, Clinical science.

Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies

S. Dimauro, M. Mancuso, M. Filosto, 2003, Annals of neurology.

Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells

L. Juillerat-Jeanneret, F. Cengelli, Blanka Halamoda Kenzaoui, 2012, International journal of nanomedicine.

ISOCYP-TOX: A new ready-to-use concept for in vitro evaluation of biotransformation-mediated toxicity

G. Quintás, M. Fabre, M. R. Vilá, 2010 .

Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.

Albrecht Poth, Cyrille Krul, Maya R Vilà, 2012, Toxicology in vitro : an international journal published in association with BIBRA.

Screening of cacna1a and ATP1A2 genes in hemiplegic migraine: clinical, genetic and functional studies

R. Corominas, N. Fernàndez-Castillo, B. Cormand, 2013, The Journal of Headache and Pain.